Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?

Schmid, Sabine; Früh, Martin; Peters, Solange

Schmid, Sabine; Früh, Martin; Peters, Solange.

Afiliación

Schmid S; Department of Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland; Department of Medical Oncology Lung Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Früh M; Department of Oncology and Hematology, Cantonal Hospital St Gallen, St Gallen, Switzerland; Department of Medical Oncology, University of Berne, Berne, Switzerland.
Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, CH-1011 Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.

Lancet Oncol ; 21(3): 320-322, 2020 03.

Article en En | MEDLINE | ID: mdl-32027845

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Acrilamidas; Compuestos de Anilina; Receptores ErbB/genética; Humanos; Mutación; Inhibidores de Proteínas Quinasas; Pirazinas; Triazinas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google